Literature DB >> 6248244

Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA.

J J O'Rear, S Mizutani, G Hoffman, M Fiandt, H M Temin.   

Abstract

Ten clones of Charon 4A containing proviruses of spleen necrosis virus, an avian retrovirus, and flanking chicken DNA sequences were isolated and characterized. Some clones gave rise to progeny with viral DNA sequences deleted or duplicated, probably as a result of crossing-over in the 600 bp terminal redundancy in viral DNA. The cellular sequences are different in each clone, indicating that all the proviruses are integrated in different sites in cellular DNA. Six clones are infectious and four are not. All the infectious molecules containing a provirus are of a similar size and are smaller than the noninfectious molecules containing a provirus. The viral DNA is not apparently different in eight clones, but two clones, one infectious and one noninfectious, lack two restriction sites each. Large changes in proviral DNA therefore do not seem responsible for the lack of infectivity of some clones. These results are consistent with the hypothesis that neighboring cellular DNA sequences control proviral expression (infectivity).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248244     DOI: 10.1016/0092-8674(80)90628-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Transforming viruses spontaneously arise from nontransforming reticuloendotheliosis virus strain T-derived viruses as a result of increased accumulation of spliced viral RNA.

Authors:  C K Miller; J E Embretson; H M Temin
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

2.  Copackaging of different-sized retroviral genomic RNAs: little effect on retroviral replication or recombination.

Authors:  J S Jones; R W Allan; B Seufzer; H M Temin
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Alteration of location of dimer linkage sequence in retroviral RNA: little effect on replication or homologous recombination.

Authors:  J S Jones; R W Allan; H M Temin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Integration of Rous sarcoma virus DNA into chicken embryo fibroblasts: no preferred proviral acceptor site in the DNA of clones of singly infected transformed chicken cells.

Authors:  T L Lerner; A M Skalka; H Hanafusa
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

5.  Tandem duplication of the proviral DNA in an avian sarcoma virus-transformed quail clone.

Authors:  T W Hsu; J M Taylor; C Aldrich; J B Townsend; G Seal; W S Mason
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning.

Authors:  K Harbers; A Schnieke; H Stuhlmann; D Jähner; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Infectivity and structure of molecular clones obtained from two genetically transmitted Moloney leukemia proviral genomes.

Authors:  K Harbers; A Schnieke; H Stuhlmann; R Jaenisch
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

8.  The changes in proviral chromatin that accompany morphological variation in avian sarcoma virus-infected rat cells.

Authors:  D J Chiswell; D A Gillespie; J A Wyke
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

9.  Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA.

Authors:  N R Rice; R R Hiebsch; M A Gonda; H R Bose; R V Gilden
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

10.  Cloning of two genetically transmitted Moloney leukemia proviral genomes: correlation between biological activity of the cloned DNA and viral genome activation in the animal.

Authors:  I Chumakov; H Stuhlmann; K Harbers; R Jaenisch
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.